Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Conditions: Prostate Cancer

Sex: Male

Ages: 18 Years – 95 Years

Enrollment: 2500

Sponsor: IRCCS San Raffaele

Location: IRCCS San Raffaele Scientific Institute Milan

Summary

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024

Eligibility Criteria

Inclusion Criteria: * Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT Exclusion Criteria: * other tumors * \> 95 years old

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06546267). StuddyBuddy aggregates publicly available trial information.